Review retinoid x receptors: X-ploring their (patho)physiological functions

Cell Death and Differentiation

Volumn 11, Issue , 2004, Pages S126-S143

  Szanto, A ^a   Narkar, V ^b   Shen, Q ^b   Uray, I P ^b   Davies, P J A ^b   Nagy, L ^a,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Nuclear receptor; Retinoid; Rexinoid; Rxr; Transcription

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; CELL NUCLEUS RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID DERIVATIVE; RETINOID X RECEPTOR; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; SULFONYLUREA; TRANSCRIPTION FACTOR;

APOPTOSIS; ATHEROSCLEROSIS; BODY WEIGHT DISORDER; BONE MARROW CELL; CELL DIFFERENTIATION; DIMERIZATION; DRUG TARGETING; GENE EXPRESSION; HUMAN; METAZOON; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; WEIGHT GAIN;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; HUMANS; INSULIN RESISTANCE; LIGANDS; PHYLOGENY; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTORS;

EID: 12844252576     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401533     Document Type: Review

References (205)

1. Petkovich M, Brand NJ, Krust A and Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 3306147: 444–450
2. Giguere V, Ong ES, Segui P and Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 3306149: 624–629
3. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG and Evans RM (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 3186047: 635–641
4. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P and Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 3206058: 134–139
5. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 2404854: 889–895
6. Mangelsdorf DJ and Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 836: 841–850
7. Mangelsdorf DJ, Ong ES, Dyck JA and Evans RM (1990) Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 3456272: 224–229
8. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK and Rosenfeld MG (1991) RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 676: 1251–1266
9. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM and Mader S (1992) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 682: 377–395
10. Hallenbeck PL, Marks MS, Lippoldt RE, Ozato K and Nikodem VM (1992) Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXR beta) enhances DNA binding and TH-dependent transcriptional activation. Proc. Natl. Acad. Sci. USA 8912: 5572–5576
11. Berrodin TJ, Marks MS, Ozato K, Linney E and Lazar MA (1992) Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein. Mol. Endocrinol. 69: 1468–1478
12. Bugge TH, Pohl J, Lonnoy O and Stunnenberg HG (1992) RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J. 114: 1409–1418
13. Kliewer SA, Umesono K, Mangelsdorf DJ and Evans RM (1992) Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 3556359: 446–449
14. Gearing KL, Gottlicher M, Teboul M, Widmark E and Gustafsson JA (1993) Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA 904: 1440–1444
15. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 109: 940–954
16. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 682: 397–406
17. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M and Lovey A (1992) 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 3556358: 359–361
18. Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI and Pfahl M (1992) Retinoids selective for retinoid X receptor response pathways. Science 2585090: 1944–1946
19. Boehm MF, Zhang L, Zhi L, McClurg MR, Berger E, Wagoner M, Mais DE, Suto CM, Davies JA and Heyman RA (1995) Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 3816: 3146–3155
20. Beard RL, Colon DF, Song TK, Davies PJ, Kochhar DM and Chandraratna RA (1996) Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid. J. Med. Chem. 3918: 3556–3563
21. Mukherjee R, Davies PJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM, Paterniti Jr JR and Heyman RA (1997) Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature: 407–410
22. Perlmann T and Jansson L (1995) A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR Genes Dev. 97: 769–782
23. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA and Mangelsdorf DJ (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 99: 1033–1045
24. Kersten S, Kelleher D, Chambon P, Gronemeyer H and Noy N (1995) Retinoid X receptor alpha forms tetramers in solution. Proc. Natl. Acad. Sci. USA 9219: 8645–8649
25. Chen ZP, Iyer J, Bourguet W, Held P, Mioskowski C, Lebeau L, Noy N, Chambon P and Gronemeyer H (1998) Ligand- and DNA-induced dissociation of RXR tetramers. J. Mol. Biol. 2751: 55–65
26. Gampe Jr RT, Montana VG, Lambert MH, Wisely GB, Milburn MV and Xu HE (2000) Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes Dev. 1417: 2229–2241
27. Egea PF, Rochel N, Birck C, Vachette P, Timmins PA and Moras D (2001) Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J. Mol. Biol. 3072: 557–576
28. Vivat-Hannah V, Bourguet W, Gottardis M and Gronemeyer H (2003) Separation of retinoid X receptor homo- and heterodimerization functions. Mol. Cell. Biol. 2321: 7678–7688
29. A IJ, Tan NS, Gelman L, Kersten S, Seydoux J, Xu J, Metzger D, Canaple L, Chambon P, Wahli W and Desvergne B (2004) In vivo activation of PPAR target genes by RXR homodimers. EMBO J. 2310: 2083–2091
30. Lenhard JM, Lancaster ME, Paulik MA, Weiel JE, Binz JG, Sundseth SS, Gaskill BA, Lightfoot RM and Brown HR (1999) The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction. Diabetologia 425: 545–554
31. Davies PJ, Berry SA, Shipley GL, Eckel RH, Hennuyer N, Crombie DL, Ogilvie KM, Peinado-Onsurbe J, Fievet C, Leibowitz MD, Heyman RA and Auwerx J (2001) Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. Mol. Pharmacol. 592: 170–176
32. Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P and Davies PJ (2001) Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol. Pharmacol. 594: 765–773
33. Shen Q, Cline GW, Shulman GI, Leibowitz MD and Davies PJ (2004) Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice. J. Biol. Chem. 27919: 19721–19731
34. Miesfeld R, Okret S, Wikstrom AC, Wrange O, Gustafsson JA and Yamamoto KR (1984) Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature 3125996: 779–781
35. Govindan MV, Devic M, Green S, Gronemeyer H and Chambon P (1985) Cloning of the human glucocorticoid receptor cDNA. Nucleic Acids Res. 1323: 8293–8304
36. Weinberger C, Hollenberg SM, Ong ES, Harmon JM, Brower ST, Cidlowski J, Thompson EB, Rosenfeld MG and Evans RM (1985) Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 2284700: 740–742
37. Sluder AE and Maina CV (2001) Nuclear receptors in nematodes: themes and variations. Trends Genet. 174: 206–213
38. Escriva Garcia H, Laudet V and Robinson-Rechavi M (2003) Nuclear receptors are markers of animal genome evolution. J. Struct. Funct. Genom. 31–4: 177–184
39. Escriva H, Safi R, Hanni C, Langlois MC, Saumitou-Laprade P, Stehelin D, Capron A, Pierce R and Laudet V (1997) Ligand binding was acquired during evolution of nuclear receptors. Proc. Natl. Acad. Sci. USA 9413: 6803–6808
40. Escriva H, Delaunay F and Laudet V (2000) Ligand binding and nuclear receptor evolution. Bioessays 228: 717–727
41. Owen GI and Zelent A (2000) Origins and evolutionary diversification of the nuclear receptor superfamily. Cell. Mol. Life Sci. 575: 809–827
42. Nomenclature. (1999) A unified nomenclature system for the nuclear receptor superfamily. Cell 972: 161–163
43. Thornton JW, Need E and Crews D (2003) Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 3015640: 1714–1717
44. Kostrouch Z, Kostrouchova M, Love W, Jannini E, Piatigorsky J and Rall JE (1998) Retinoic acid X receptor in the diploblast, Tripedalia cystophora. Proc. Natl. Acad. Sci. USA 9523: 13442–13447
45. Wiens M, Batel R, Korzhev M and Muller WE (2003) Retinoid X receptor and retinoic acid response in the marine sponge Suberites domuncula. J. Exp. Biol. 206Pt: 18:3261–18:3271
46. Henrich VC, Sliter TJ, Lubahn DB, MacIntyre A and Gilbert LI (1990) A steroid/thyroid hormone receptor superfamily member in Drosophila melanogaster that shares extensive sequence similarity with a mammalian homologue. Nucleic Acids Res. 1814: 4143–4148
47. Oro AE, McKeown M and Evans RM (1990) Relationship between the product of the Drosophila ultraspiracle locus and the vertebrate retinoid X receptor. Nature 3476290: 298–301
48. Billas IM, Moulinier L, Rochel N and Moras D (2001) Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects. J. Biol. Chem. 27610: 7465–7474
49. Clayton GM, Peak-Chew SY, Evans RM and Schwabe JW (2001) The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation. Proc. Natl. Acad. Sci. USA 984: 1549–1554
50. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M and Chambon P (1995) The nuclear receptor superfamily: the second decade. Cell 836: 835–839
51. Zilliacus J, Carlstedt-Duke J, Gustafsson JA and Wright AP (1994) Evolution of distinct DNA-binding specificities within the nuclear receptor family of transcription factors. Proc. Natl. Acad. Sci. USA 9110: 4175–4179
52. Laudet V (1997) Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. J. Mol. Endocrinol. 193: 207–226
53. Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H and Moras D (2000) Crystal structure of a heterodimeric complex of RAR and RXR ligandbinding domains. Mol. Cell 52: 289–298
54. Gampe Jr RT, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, Kliewer SA, Willson TM and Xu HE (2000) Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 53: 545–555
55. Kersten S, Gronemeyer H and Noy N (1997) The DNA binding pattern of the retinoid X receptor is regulated by ligand-dependent modulation of its oligomeric state. J. Biol. Chem. 27219: 12771–12777
56. Kersten S, Dong D, Lee W, Reczek PR and Noy N (1998) Auto-silencing by the retinoid X receptor. J. Mol. Biol. 2841: 21–32
57. Heery DM, Kalkhoven E, Hoare S and Parker MG (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 3876634: 733–736
58. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ and Yamamoto KR (1998) Structure and specificity of nuclear receptor–coactivator interactions. Genes Dev. 1221: 3343–3356
59. Hu X and Lazar MA (1999) The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 4026757: 93–96
60. Nagy L, Kao HY, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM and Schwabe JW (1999) Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 1324: 3209–3216
61. Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK and Rosenfeld MG (1999) Molecular determinants of nuclear receptor–corepressor interaction. Genes Dev. 1324: 3198–3208
62. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK and Milburn MV (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptorgamma. Nature 3956698: 137–143
63. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA and Greene GL (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 957: 927–937
64. Nagy L and Schwabe JW (2004) Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 296: 317–324
65. Zhang J, Hu X and Lazar MA (1999) A novel role for helix 12 of retinoid X receptor in regulating repression. Mol. Cell. Biol. 199: 6448–6457
66. Westin S, Kurokawa R, Nolte RT, Wisely GB, McInerney EM, Rose DW, Milburn MV, Rosenfeld MG and Glass CK (1998) Interactions controlling the assembly of nuclear–receptor heterodimers and co-activators. Nature 3956698: 199–202
67. Vivat V, Zechel C, Wurtz JM, Bourguet W, Kagechika H, Umemiya H, Shudo K, Moras D, Gronemeyer H and Chambon P (1997) A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J. 1618: 5697–5709
68. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A and Evans RM (1992) Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 63: 329–344
69. Lemotte PK, Keidel S and Apfel CM (1996) Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 2361: 328–333
70. de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J and Perlmann T (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2905499: 2140–2144
71. Solomin L, Johansson CB, Zetterstrom RH, Bissonnette RP, Heyman RA, Olson L, Lendahl U, Frisen J and Perlmann T (1998) Retinoid-X receptor signalling in the developing spinal cord. Nature 3956700: 398–402
72. Luria A and Furlow JD (2004) Spatiotemporal retinoid-X receptor activation detected in live vertebrate embryos. Proc. Natl. Acad. Sci. USA 10124: 8987–8992
73. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR and Evans RM (1994) RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 89: 1007–1018
74. Kastner P, Grondona JM, Mark M, Gansmuller A, LeMeur M, Decimo D, Vonesch JL, Dolle P and Chambon P (1994) Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 786: 987–1003
75. Gruber PJ, Kubalak SW, Pexieder T, Sucov HM, Evans RM and Chien KR (1996) RXR alpha deficiency confers genetic susceptibility for aortic sac conotruncal, atrioventricular cushion, and ventricular muscle defects in mice. J. Clin. Invest. 986: 1332–1343
76. Dyson E, Sucov HM, Kubalak SW, Schmid-Schonbein GW, DeLano FA, Evans RM, Ross Jr J and Chien KR (1995) Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha_/_ mice. Proc. Natl. Acad. Sci. USA 9216: 7386–7390
77. Kastner P, Mark M, Ghyselinck N, Krezel W, Dupe V, Grondona JM and Chambon P (1997) Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 1242: 313–326
78. Ruiz-Lozano P, Smith SM, Perkins G, Kubalak SW, Boss GR, Sucov HM, Evans RM and Chien KR (1998) Energy deprivation and a deficiency in downstream metabolic target genes during the onset of embryonic heart failure in RXRalpha embryos. Development 1253: 533–544
79. Chen J, Kubalak SW and Chien KR (1998) Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development 12510: 1943–1949
80. Tran CM and Sucov HM (1998) The RXRalpha gene functions in a non-cellautonomous manner during mouse cardiac morphogenesis. Development 12510: 1951–1956
81. Subbarayan V, Mark M, Messadeq N, Rustin P, Chambon P and Kastner P (2000) RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses. J. Clin. Invest. 1053: 387–394
82. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M and Chambon P (1993) Function of retinoic acid receptor gamma in the mouse. Cell 734: 643–658
83. Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, Gansmuller A and Chambon P (1994) Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development 12010: 2723–2748
84. Ross SA, McCaffery PJ, Drager UC and De Luca LM (2000) Retinoids in embryonal development. Physiol. Rev. 803: 1021–1054
85. Sucov HM, Izpisua-Belmonte JC, Ganan Y and Evans RM (1995) Mouse embryos lacking RXR alpha are resistant to retinoic-acid-induced limb defects. Development 12112: 3997–4003
86. Nugent P, Sucov HM, Pisano MM and Greene RM (1999) The role of RXRalpha in retinoic acid-induced cleft palate as assessed with the RXR-alpha knockout mouse. Int. J. Dev. Biol. 436: 567–570
87. Sapin V, Ward SJ, Bronner S, Chambon P and Dolle P (1997) Differential expression of transcripts encoding retinoid binding proteins and retinoic acid receptors during placentation of the mouse. Dev. Dyn. 2082: 199–210
88. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A and Evans RM (1999) PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 44: 585–595
89. Wendling O, Chambon P and Mark M (1999) Retinoid X receptors are essential for early mouse development and placentogenesis. Proc. Natl. Acad. Sci. USA 962: 547–551
90. Kastner P, Mark M, Leid M, Gansmuller A, Chin W, Grondona JM, Decimo D, Krezel W, Dierich A and Chambon P (1996) Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev. 101: 80–92
91. Krezel W, Dupe V, Mark M, Dierich A, Kastner P and Chambon P (1996) RXR gamma null mice are apparently normal and compound RXR alpha +/_/RXR beta _/_/RXR gamma _/_ mutant mice are viable. Proc. Natl. Acad. Sci. USA 9317: 9010–9014
92. Brown NS, Smart A, Sharma V, Brinkmeier ML, Greenlee L, Camper SA, Jensen DR, Eckel RH, Krezel W, Chambon P and Haugen BR (2000) Thyroid hormone resistance and increased metabolic rate in the RXR-gammadeficient mouse. J. Clin. Invest. 1061: 73–79
93. Chiang MY, Misner D, Kempermann G, Schikorski T, Giguere V, Sucov HM, Gage FH, Stevens CF and Evans RM (1998) An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression. Neuron 216: 1353–1361
94. Krezel W, Ghyselinck N, Samad TA, Dupe V, Kastner P, Borrelli E and Chambon P (1998) Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 2795352: 863–867
95. Mascrez B, Mark M, Dierich A, Ghyselinck NB, Kastner P and Chambon P (1998) The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. Development 12523: 4691–4707
96. Mascrez B, Mark M, Krezel W, Dupe V, LeMeur M, Ghyselinck NB and Chambon P (2001) Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. Development 12811: 2049–2062
97. Tarrade A, Schoonjans K, Pavan L, Auwerx J, Rochette-Egly C, Evain-Brion D and Fournier T (2001) PPARgamma/RXRalpha heterodimers control human trophoblast invasion. J. Clin. Endocrinol. Metab. 8610: 5017–5024
98. Tarrade A, Schoonjans K, Guibourdenche J, Bidart JM, Vidaud M, Auwerx J, Rochette-Egly C and Evain-Brion D (2001) PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology 14210: 4504–4514
99. Imai T, Jiang M, Chambon P and Metzger D (2001) Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre- ERT2) in adipocytes. Proc. Natl. Acad. Sci. USA 981: 224–228
100. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM and Mortensen RM (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 44: 611–617
101. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S and Kadowaki T (1999) PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 44: 597–609
102. Li M, Indra AK, Warot X, Brocard J, Messaddeq N, Kato S, Metzger D and Chambon P (2000) Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature 4076804: 633–636
103. Li M, Chiba H, Warot X, Messaddeq N, Gerard C, Chambon P and Metzger D (2001) RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 1285: 675–688
104. Wan YJ, An D, Cai Y, Repa JJ, Hung-Po Chen T, Flores M, Postic C, Magnuson MA, Chen J, Chien KR, French S, Mangelsdorf DJ and Sucov HM (2000) Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell. Biol. 2012: 4436–4444
105. Wan YJ, Han G, Cai Y, Dai T, Konishi T and Leng AS (2003) Hepatocyte retinoid X receptor-alpha-deficient mice have reduced food intake, increased body weight, and improved glucose tolerance. Endocrinology 1442: 605–611
106. Wan YJ, Cai Y, Lungo W, Fu P, Locker J, French S and Sucov HM (2000) Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice. J. Biol. Chem. 27536: 28285–28290
107. Imai T, Jiang M, Kastner P, Chambon P and Metzger D (2001) Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity. Proc. Natl. Acad. Sci. USA 988: 4581–4586
108. Huang J, Powell WC, Khodavirdi AC, Wu J, Makita T, Cardiff RD, Cohen MB, Sucov HM and Roy-Burman P (2002) Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res. 6216: 4812–4819
109. Iulianella A and Lohnes D (2002) Chimeric analysis of retinoic acid receptor function during cardiac looping. Dev. Biol. 2471: 62–75
110. Napoli JL, Boerman MH, Chai X, Zhai Y and Fiorella PD (1995) Enzymes and binding proteins affecting retinoic acid concentrations. J. Steroid Biochem. Mol. Biol. 531–6: 497–502
111. Bhat PV, Bader T, Nettesheim P and Jetten AM (1998) Differentiationdependent regulation of retinal dehydrogenase gene expression in the trachea. Biochem. Cell Biol. 761: 59–62
112. Mic FA, Haselbeck RJ, Cuenca AE and Duester G (2002) Novel retinoic acid generating activities in the neural tube and heart identified by conditional rescue of Raldh2 null mutant mice. Development 1299: 2271–2282
113. Cui J, Michaille JJ, JiangWand Zile MH (2003) Retinoid receptors and vitamin A deficiency: differential patterns of transcription during early avian development and the rapid induction of RARs by retinoic acid. Dev. Biol. 2602: 496–511
114. Huss JM, Levy FH and Kelly DP (2001) Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J. Biol. Chem. 27629: 27605–27612
115. Barger PM and Kelly DP (1999) Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am. J. Med. Sci. 3181: 36–42
116. Osorio JC, Stanley WC, Linke A, Castellari M, Diep QN, Panchal AR, Hintze TH, Lopaschuk GD and Recchia FA (2002) Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 1065: 606–612
117. Feingold K, Kim MS, Shigenaga J, Moser A and Grunfeld C (2004) Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am. J. Physiol. Endocrinol. Metab. 2862: E201–E207
118. Petersen KF and Shulman GI (2002) Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am. J. Cardiol. 905A: 11G–18G
119. Cha BS, Ciaraldi TP, Carter L, Nikoulina SE, Mudaliar S, Mukherjee R, Paterniti Jr JR and Henry RR (2001) Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia 444: 444–452
120. Bonen A, Dyck DJ, Ibrahimi A and Abumrad NA (1999) Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD Am. J. Physiol. 2764 (Part 1): E642–E649
121. Luiken JJ, Han XX, Dyck DJ and Bonen A (2001) Coordinately regulated expression of FAT/CD36 and FACS1 in rat skeletal muscle. Mol. Cell. Biochem. 2231–2: 61–69
122. Peters SJ, Harris RA, Wu P, Pehleman TL, Heigenhauser GJ and Spriet LL (2001) Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/low-carbohydrate diet. Am. J. Physiol. Endocrinol. Metab. 2816: E1151–E1158
123. Samec S, Seydoux J, Russell AP, Montani JP and Dulloo AG (2002) Skeletal muscle heterogeneity in fasting-induced upregulation of genes encoding UCP2, UCP3, PPARgamma and key enzymes of lipid oxidation. Pflugers Arch. 4451: 80–86
124. Pilegaard H, Saltin B and Neufer PD (2003) Effect of short-term fasting and refeeding on transcriptional regulation of metabolic genes in human skeletal muscle. Diabetes 523: 657–662
125. Wang S, Subramaniam A, Cawthorne MA and Clapham JC (2003) Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle. Diabetes Obes. Metab. 55: 295–301
126. Himms-Hagen J and Harper ME (2001) Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp. Biol. Med. (Maywood) 2262: 78–84
127. Majer M, Popov KM, Harris RA, Bogardus C and Prochazka M (1998) Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Mol. Genet. Metab. 652: 181–186
128. Enoch HG and Strittmatter P (1978) Role of tyrosyl and arginyl residues in rat liver microsomal stearylcoenzyme A desaturase. Biochemistry 1723: 4927–4932
129. Montell E, Turini M, Marotta M, Roberts M, Noe V, Ciudad CJ, Mace K and Gomez-Foix AM (2001) DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am. J. Physiol. Endocrinol. Metab. 2802: E229–E237
130. Itani SI, Ruderman NB, Schmieder F and Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 517: 2005–2011
131. Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G and Olefsky JM (2002) Fatty acid-induced insulin resistance: decreased muscle PI3 K activation but unchanged Akt phosphorylation. J. Clin. Endocrinol. Metab. 871: 226–234
132. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW and Shulman GI (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 27752: 50230–50236
133. Chavez JA and Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 4192: 101–109
134. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL and Summers SA (2003) A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J. Biol. Chem. 27812: 10297–10303
135. Bonen A, Tan MH and Watson-Wright WM (1981) Insulin binding and glucose uptake differences in rodent skeletal muscles. Diabetes 308: 702–704
136. James DE, Kraegen EW and Chisholm DJ (1985) Muscle glucose metabolism in exercising rats: comparison with insulin stimulation. Am. J. Physiol. 2485 (Part 1): E575–E580
137. Jiang G, Dallas-Yang Q, Li Z, Szalkowski D, Liu F, Shen X, Wu M, Zhou G, Doebber T, Berger J, Moller DE and Zhang BB (2002) Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists. Diabetes 518: 2412–2419
138. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG and Dohm GL (1995) Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am. J. Physiol. 2683 (Part 1): E453–E457
139. Kriketos AD, Pan DA, Lillioja S, Cooney GJ, Baur LA, Milner MR, Sutton JR, Jenkins AB, Bogardus C and Storlien LH (1996) Interrelationships between muscle morphology, insulin action, and adiposity. Am. J. Physiol. 2706 (Part 2): R1332–R1339
140. Higashiura K, Ura N, Takada T, Agata J, Yoshida H, Miyazaki Y and Shimamoto K (1999) Alteration of muscle fiber composition linking to insulin resistance and hypertension in fructose-fed rats. Am. J. Hypertens. 126: 596–602
141. Nagase I, Yoshida S, Canas X, Irie Y, Kimura K, Yoshida T and Saito M (1999) Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes. FEBS Lett. 4613: 319–322
142. Solanes G, Pedraza N, Iglesias R, Giralt M and Villarroya F (2000) The human uncoupling protein-3 gene promoter requires MyoD and is induced by retinoic acid in muscle cells. FASEB J. 1414: 2141–2143
143. Rieusset J, Roques M, Bouzakri K, Chevillotte E and Vidal H (2001) Regulation of p85alpha phosphatidylinositol-3-kinase expression by peroxisome proliferator-activated receptors (PPARs) in human muscle cells. FEBS Lett. 5023: 98–102
144. Way JM, Harrington WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield TA, Ramachandran RK, Willson TM and Kliewer SA (2001) Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferatoractivated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology 1423: 1269–1277
145. Minnich A, Tian N, Byan L and Bilder G (2001) A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2802: E270–E279
146. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL and Kraus WE (2002) Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 27729: 26089–26097
147. Muoio DM, Way JM, Tanner CJ, Winegar DA, Kliewer SA, Houmard JA, Kraus WE and Dohm GL (2002) Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 514: 901–909
148. Zhang J, Phillips DI, Wang C and Byrne CD (2004) Human skeletal muscle PPARalpha expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 2862: E168–E175
149. Lee HJ, Choi SS, Park MK, An YJ, Seo SY, Kim MC, Hong SH, Hwang TH, Kang DY, Garber AJ and Kim DK (2002) Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem. Biophys. Res. Commun. 2962: 293–299
150. Picard F and Auwerx J (2002) PPAR(gamma) and glucose homeostasis. Annu. Rev. Nutr. 22: 167–197
151. Oakes ND, Camilleri S, Furler SM, Chisholm DJ and Kraegen EW (1997) The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism 468: 935–942
152. Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI and Petersen KF (2002) The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 513: 797–802
153. Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K and Olefsky JM (1997) TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 4611: 1678–1683
154. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS and Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 4096818: 307–312
155. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O’Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE and Moller DE (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 1433: 998–1007
156. Burant CF, Sreenan S, Hirano K, Tai TA, Lohmiller J, Lukens J, Davidson NO, Ross S and Graves RA (1997) Troglitazone action is independent of adipose tissue. J. Clin. Invest. 10011: 2900–2908
157. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE and Henry RR (1998) Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects. J. Clin. Endocrinol. Metab. 835: 1636–1643
158. Yonemitsu S, Nishimura H, Shintani M, Inoue R, Yamamoto Y, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Hayashi T and Nakao K (2001) Troglitazone induces GLUT4 translocation in L6 myotubes. Diabetes 505: 1093–1101
159. Glazier AM, Scott J and Aitman TJ (2002) Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mamm. Genome 132: 108–113
160. Pessin JE and Saltiel AR (2000) Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 1062: 165–169
161. Miller VA, Benedetti FM, Rigas JR, Verret AL, Pfister DG, Straus D, Kris MG, Crisp M, Heyman R, Loewen GR, Truglia JA and Warrell Jr. RP (1997) Initial clinical trial of a selective retinoid X receptor ligand, LGD J. Clin. Oncol. 152: 790–795
162. Cao G, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, Zhang Y, Stayrook KR, Suen C, Otto KA, Miller AR, Dai J, Foxworthy P, Gao H, Ryan TP, Jiang XC, Burris TP, Eacho PI and Etgen GJ (2003) Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J. Biol. Chem. 2782: 1131–1136
163. Lusis AJ (2000) Atherosclerosis. Nature 4076801: 233–241
164. Glass CK and Witztum JL (2001) Atherosclerosis. The road ahead. Cell 1044: 503–516
165. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL and Boren J (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 4176890: 750–754
166. Nagy L, Tontonoz P, Alvarez JG, Chen H and Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 932: 229–240
167. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA and Evans RM (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 932: 241–252
168. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM and Mangelsdorf DJ (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2895484: 1524–1529
169. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM and Tontonoz P (2001) A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 71: 161–171
170. Kennedy MA, Venkateswaran A, Tarr PT, Xenarios I, Kudoh J, Shimizu N and Edwards PA (2001) Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J. Biol. Chem. 27642: 39438–39447
171. Willy PJ and Mangelsdorf DJ (1997) Unique requirements for retinoiddependent transcriptional activation by the orphan receptor LXR. Genes Dev. 113: 289–298
172. Szanto A, Benko S, Szatmari I, Balint BL, Furtos I, Ruhl R, Molnar S, Csiba L, Garuti R, Calandra S, Larsson H, Diczfalusy U and Nagy L (2004) Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol. Cell. Biol. 2418: 8154–8166
173. Hulten LM, Lindmark H, Diczfalusy U, Bjorkhem I, Ottosson M, Liu Y, Bondjers G and Wiklund O (1996) Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocytederived macrophages. J. Clin. Invest. 972: 461–468
174. Crisby M, Nilsson J, Kostulas V, Bjorkhem I and Diczfalusy U (1997) Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques. Biochim. Biophys. Acta 13443: 278–285
175. Cali JJ, Hsieh CL, Francke U and Russell DW (1991) Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 26612: 7779–7783
176. Bjorkhem I and Leitersdorf E (2000) Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans. Trends Endocrinol. Metab. 115: 180–183
177. Bjorkhem I and Leitersdorf E (2002) Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch. Neurol. 594: 527–529
178. Lu TT, Repa JJ and Mangelsdorf DJ (2001) Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J. Biol. Chem. 27641: 37735–37738
179. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J and Mangelsdorf DJ (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 63: 507–515
180. Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE and Schmitz G (1999) Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 2571: 29–33
181. Claudel T, Leibowitz MD, Fievet C, Tailleux A, Wagner B, Repa JJ, Torpier G, Lobaccaro JM, Paterniti JR, Mangelsdorf DJ, Heyman RA and Auwerx J (2001) Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc. Natl. Acad. Sci. USA 985: 2610–2615
182. Collins SJ (2002) The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 1610: 1896–1905
183. Defacque H, Commes T, Legouffe E, Sevilla C, Rossi JF, Rochette-Egly C and Marti J (1996) Expression of retinoid X receptor alpha is increased upon monocytic cell differentiation. Biochem. Biophys. Res. Commun. 2202: 315–322
184. Duprez E, Lillehaug JR, Gaub MP and Lanotte M (1996) Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Oncogene 1211: 2443–2450
185. Nagy L, Thomazy VA, Heyman RA and Davies PJ (1998) Retinoid-induced apoptosis in normal and neoplastic tissues. Cell. Death Differ. 51: 11–19
186. Lehmann S, Paul C and Torma H (2001) Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells. Clin. Cancer Res. 72: 367–373
187. Sunaga S, Maki K, Lagasse E, Blanco JC, Ozato K, Miyazaki J and Ikuta K (1997) Myeloid differentiation is impaired in transgenic mice with targeted expression of a dominant negative form of retinoid X receptor beta. Br. J. Haematol. 961: 19–30
188. Mehta K, McQueen T, Neamati N, Collins S and Andreeff M (1996) Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ. 72: 179–186
189. Shiohara M, Dawson MI, Hobbs PD, Sawai N, Higuchi T, Koike K, Komiyama A and Koeffler HP (1999) Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Blood 936: 2057–2066
190. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamph W, Heyman RA, Chandraratna RA and Davies PJ (1995) Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 157: 3540–3551
191. Johnson BS, Chandraratna RA, Heyman RA, Allegretto EA, Mueller L and Collins SJ (1999) Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. Mol. Cell. Biol. 195: 3372–3382
192. Benoit G, Altucci L, Flexor M, Ruchaud S, Lillehaug J, Raffelsberger W, Gronemeyer H and Lanotte M (1999) RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J. 1824: 7011–7018
193. Nagy L, Thomazy VA, Chandraratna RA, Heyman RA and Davies PJ (1996) Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leukemia Res. 206: 499–505
194. Benoit GR, Flexor M, Besancon F, Altucci L, Rossin A, Hillion J, Balajthy Z, Legres L, Segal-Bendirdjian E, Gronemeyer H and Lanotte M (2001) Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. Mol. Endocrinol. 157: 1154–1169
195. Altucci L and Gronemeyer H (2002) Decryption of the retinoid death code in leukemia. J. Clin. Immunol. 223: 117–123
196. Clifford J, Chiba H, Sobieszczuk D, Metzger D and Chambon P (1996) RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J. 1516: 4142–4155
197. Wu Q, Dawson MI, Zheng Y, Hobbs PD, Agadir A, Jong L, Li Y, Liu R, Lin B and Zhang XK (1997) Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol. Cell. Biol. 1711: 6598–6608
198. Tanaka T, Dancheck BL, Trifiletti LC, Birnkrant RE, Taylor BJ, Garfield SH, Thorgeirsson U and De Luca LM (2004) Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells. Mol. Cell. Biol. 249: 3972–3982
199. Toma S, Isnardi L, Riccardi L and Bollag W (1998) Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids. Anticancer Res. 182A: 935–942
200. Lomo J, Smeland EB, Ulven S, Natarajan V, Blomhoff R, Gandhi U, Dawson MI and Blomhoff HK (1998) RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J. Cell. Physiol. 1751: 68–77
201. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM and Cohen P (2000) Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J. Biol. Chem. 27543: 33607–33613
202. Fan YY, Spencer TE, Wang N, Moyer MP and Chapkin RS (2003) Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 249: 1541–1548
203. Balasubramanian S, Chandraratna RA and Eckert RL (2004) Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid. Carcinogenesis 258: 1377–1385
204. Bourguet W, Ruff M, Chambon P, Gronemeyer H and Moras D (1995) Crystal structure of the ligand-binding domain of the human nuclear receptor RXRalpha. Nature 3756530: 377–382
205. Egea PF, Mitschler A, Rochel N, Ruff M, Chambon P and Moras D (2000) Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J. 1911: 2592–2601